Search Results

Your search matched 1 results


Why the Pharmaceutical Revolutions of Tomorrow Will Start With the Science and Lead With a Great Story | Blog

More than 20 years ago, Gleevec ushered in a therapeutic revolution in oncology based on a relatively simple premise: If cancer cells are “addicted” to oncogenic mutations, targeting the troublesome protein might provide long-lasting disease control.